Senthil Sundaram - Chief Executive Officer, Director at Terns Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
TERN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Senthil Sundaram since 9/17/2023

Holdings reported by Senthil Sundaram for Terns Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 9.77K $36.9K $3.78 May 31, 2023 Direct
Stock Option (Right to Buy) 900K Feb 1, 2023 Direct Common Stock

Transactions reported by Senthil Sundaram for Terns Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.